Epidemiological and molecular studies suggest that Alzheimer's disease (AD) has multiple
etiologies including genetic mutations, genetic variations affecting susceptibility and …

Abstract Alzheimer's disease (AD), being the number one in terms of dementia burden, is an
insidious age-related neurodegenerative disease and is presently considered a global …

Background Alzheimer's disease (AD) is a progressive neurodegenerative disease. AD is
the main cause of dementia worldwide and aging is the main risk factor for developing the …

Alzheimer's disease (AD) is a horribly debilitating disease that will increase in prevalence as
the populations of the USA and Europe continue to age. It is expected that the USA alone …

Alzheimer′ s disease is the most common form of dementia affecting millions of individuals
worldwide. It is currently diagnosed only via clinical assessments and confirmed by …

Alzheimer disease (AD) is one of the major unresolved health burdens accompanying the
increase in life expectancy. The great paradigm shift for this disease has resulted from …

As the spectrum of therapeutic options broadens, the possibility of an early and accurate
diagnosis of Alzheimer's disease (AD), or even isolation of a group at high risk of …

Alzheimer's disease (AD) is the most common neurodegenerative disease among the
elderly, affecting millions of people worldwide and clinically characterized by a progressive …

Recent advances in biomarker studies on dementia are summarized here. CSF Aβ40, Aβ42,
total tau, and phosphorylated tau are the most sensitive biomarkers for diagnosis of …

While Alzheimer's disease (AD) classical diagnostic criteria rely on clinical data from a
stablished symptomatic disease, newer criteria aim to identify the disease in its earlier …